SYNTHESIS OF 1α,25-DIHYDROXY-2β-(3-HYDROXYPROPOXY)VITAMIN D3 (ELDECALCITOL) AND RELATED COMPOUNDS BY THE TROST CONVERGENT METHODOLOGY

被引:8
|
作者
Kubodera, Noboru [1 ]
Hatakeyama, Susumi [2 ]
机构
[1] Chugai Pharmaceut Co Ltd, Chuo Ku, Tokyo 1038324, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan
关键词
Active Vitamin D-3 Analog; Calcitriol; 1; alpha; 25-Dihydroxy-2 beta-(3-hydroxypropoxy)vitamin D-3; Eldecalcitol; Trost Convergent Methodology; VITAMIN-D ANALOGS; BONE-MINERAL LOSS; PARATHYROID-HORMONE SECRETION; OVARIECTOMIZED RATS; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3; OSTEOPOROTIC PATIENTS; BIOLOGICAL EVALUATION; POTENT SUPPRESSOR; D-RIBONOLACTONE; D METABOLITES;
D O I
10.3987/REV-08-SR(D)3
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Using Trost convergent methodology, the synthesis of 1 alpha,25-dihydroxy-2 beta-(3-hydroxypropoxy)vitamin D-3 (eldecalcitol) for the improved and industrial scale production and related putative metabolites of eldecalcitol is summarized. In addition, A-ring diastereomers at the 1- and 3-positions of eldecalcitol are described. The synthesis centers on a key palladium-catalyzed alkylative cyclization and coupling of ene-ynes that constitute the A-ring fragment to bromomethylenes comprising the C/D-ring fragment which affords the requisite triene framework of vitamin D-3 analogs.
引用
收藏
页码:145 / 162
页数:18
相关论文
共 50 条
  • [41] 1α,25-dihydroxy-3-epivitaminD3 is a circulating vitamin D3 metabolite in rats
    Sekimoto, H
    Siu-Caldera, ML
    Weiskopf, A
    Vouros, P
    Reddy, GS
    PEDIATRIC RESEARCH, 1999, 45 (04) : 97A - 97A
  • [42] The synthesis of 19-nor-1α, 25-dihydroxy-22-oxo-vitamin D3
    Wu, Y
    Guan, M
    Li, PJ
    Xu, C
    Wu, XC
    CHINESE CHEMICAL LETTERS, 2001, 12 (01) : 19 - 20
  • [43] The Synthesis of 19-Nor-1α, 25-dihydroxy-22-oxo-vitamin D3
    Yong WU*1 Mei GUAN2 Pei Jie LI1 Cheng XU1 Xiao Chun WU1 1School of Pharmacy
    ChineseChemicalLetters, 2001, (01) : 19 - 20
  • [44] 1α,25-Dihydroxy vitamin D3, the active form of vitamin D3, protects against allergeninduced airway constriction
    Maarsingh, Harm
    Remick, Adam J.
    Stimson, David T. J.
    Lopez, Alejandro
    Bolson, Anthony
    DellaVecchia, Matthew
    FASEB JOURNAL, 2019, 33
  • [45] Enzymatic Desymmetrization of 19-nor-Vitamin D3 A-Ring Synthon Precursor: Synthesis, Structure Elucidation, and Biological Activity of 1α,25-Dihydroxy-3-epi-19-nor-vitamin D3 and 1β,25-Dihydroxy-19-nor-vitamin D3
    Gonzalez-Garcia, Tania
    Verstuyf, Annemieke
    Verlinden, Lieve
    Fernandez, Susana
    Ferrero, Miguel
    ADVANCED SYNTHESIS & CATALYSIS, 2018, 360 (14) : 2762 - 2772
  • [46] Synthesis of the enantiomer of 1α,25-dihydroxy vitamin D3 (calcitriol) and a diastereomer of 1α,25-dihydroxy vitamin D3 differing from natural product in configuration at all but one asymmetric carbon atoms
    Achmatowicz, B
    Przezdziecka, A
    Wicha, J
    POLISH JOURNAL OF CHEMISTRY, 2005, 79 (02) : 413 - 428
  • [47] 1α,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1α,25-dihydroxy vitamin D3:: production and biological activity studies in pulmonary alveolar type II cells
    Rehan, VK
    Torday, JS
    Peleg, S
    Gennaro, L
    Vouros, P
    Padbury, J
    Rao, DS
    Reddy, GS
    MOLECULAR GENETICS AND METABOLISM, 2002, 76 (01) : 46 - 56
  • [48] 1α,25-Dihydroxy Vitamin D3 Induces Nuclear Matrix Association of the 1α,25-Dihydroxy Vitamin D3 Receptor in Osteoblasts Independently of Its Ability to Bind DNA
    Arriagada, Gloria
    Paredes, Roberto
    Van Wijnen, Andre J.
    Lian, Jane B.
    Van Zundert, Brigitte
    Stein, Gary S.
    Stein, Janet L.
    Montecino, Martin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 222 (02) : 336 - 346
  • [49] Coordinated effects of 1α,25-dihydroxy vitamin D3 on the immune response
    Burke, F
    Evans, KN
    Lammas, DA
    Hewison, M
    Sansom, DM
    IMMUNOLOGY, 2005, 116 : 103 - 103
  • [50] The Synthesis of an Optically Active Intermediate of A-Ring for 1α,25-Dihydroxy Vitamin D3 Analogs
    Yong WU
    and (School of Pharmacy
    ChineseChemicalLetters, 1998, (05) : 431 - 432